Sol-Gel logo — company profile

Sol-Gel

Founded 1997 Israel Israel 48 employees Venture round Biotechnology, Pharmaceutical

General Information

Company Name Sol-Gel
Founded Year 1997
Location Israel Israel
Employees 48
Industries Biotechnology, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Sol-Gel. To contact Sol-Gel, visit sol-gel.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Sol-Gel

Sol-Gel Technologies is a clinical-stage dermatology company focused on identifying, developing, and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's proprietary silica-based microencapsulation technology platform supports a pipeline of late-stage branded product candidates and several generic product candidates across multiple indications. This unique technology enables drug substances to be entrapped in porous silica microcapsules, addressing the limitations of topical drug delivery by stabilizing active drug ingredients, extending drug delivery time, and reducing potential irritation caused by direct application to the skin. Founded in 1997 and based in Israel, Sol-Gel Technologies received its last investment in a Venture Round - Sol investment at 01 January 2006 led by Jerusalem Venture Partners (JVP). The company's innovative approach to dermatology and topical drug delivery positions it as a promising player in the biotechnology and pharmaceutical industries. For more information, visit www.Sol-Gel.com.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Sol Undisclosed 1
Jerusalem Venture Partners (JVP)
01 Jan 2006

FAQ About Sol-Gel

Sol-Gel Technologies (NASDAQ: SLGL) is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Our current product candidate pipeline consists of late-stage branded product candidates th...
Sol-Gel was founded in 1997.
Sol-Gel is headquartered in Israel.
Sol-Gel operates in Biotechnology and Pharmaceutical.
Sol-Gel has approximately 48 employees.
Sol-Gel has completed 1 funding round. The latest funding stage is Venture round.

We're actively collecting intelligence on Sol-Gel.

Source: BounceWatch company record for Sol-Gel, https://bouncewatch.com/company/sol-gel, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes